Subcutaneous Administration of Otelixizumab to T1DM Patients (RAO112438)

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
GlaxoSmithKline
ClinicalTrials.gov Identifier:
NCT00946257
First received: July 23, 2009
Last updated: February 14, 2013
Last verified: January 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: July 2015
  Primary Completion Date: August 2011 (Final data collection date for primary outcome measure)